The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 11,500.00
Ask: 12,200.00
Change: 0.00 (0.00%)
Spread: 700.00 (6.087%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Britain's FTSE dips after Trump win though pharma, gold miners surge

Wed, 09th Nov 2016 09:58

(ADVISORY- Follow European and UK stock markets in real time onthe Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets)

* FTSE 100 down 0.1 pct

* Gold miners, pharma stocks rally

* U.S.-exposed firms also gain

By Kit Rees

LONDON, Nov 9 (Reuters) - Britain's top share index fell onWednesday after a shock win for Republican Donald Trump in theU.S. presidential election sent markets lower, though goldminers and pharma stocks soared.

Trump defeated favourite Hillary Clinton in Tuesday'selection, putting the U.S. on an uncertain path and promptinginvestors to dump risky assets such as stocks.

The blue chip FTSE 100 index fell 0.1 percent to6,837.87 points by 0932 GMT, having rallied in the previoussession on expectation of a Clinton victory. The moredomestically-focused FTSE 250 index rose 0.2 pct.

The FTSE 100 had opened 2 percent lower, but recovered offits lows. Analysts cited Trump's acceptance speech as soothinginvestor nerves.

"I think the market over-reacted slightly this morning,"John Moore, advisory investment manager at Berkeley Capital,said, adding that he wouldn't be surprised if the FTSE 100turned positive.

"I think Trump is pro-business. The thing is, lookingtowards the FTSE, there are several stocks that will benefitfrom a Trump victory, such as the pharmaceuticals sector.Hillary Clinton wanted to impose tighter regulations, whereasTrump is opposed to that."

Healthcare stocks Hikma, Shire, Astrazeneca and GlaxoSmithKline rallied, gaining between 2percent to 6.7 percent on the back of Trump's win.

Pharma stocks had been losing ground in the run-up to theelection on worries that a Clinton presidency would put pressureon drug prices.

Some companies with significant exposure to the United Statesalso rose. CRH a construction firm which had been toutedas a potential beneficiary from any increase in U.S.infrastructure spending, jumped 7 percent, as it derives 50percent of its revenues from there. U.S.-focused Ashtead also soared 7.6 percent.

Investors' flight to safety buoyed shares in precious metalsminer Fresnillo, which jumped over 9 percent, alongwith Randgold Resources, which gained more than 7percent after the price of gold surged.

Shares in banking stocks, however, came underpressure, while British grocers fell after Sainsbury reported an underwhelming set of results and dropped 3.2percent. The supermarket reported a third straight decline infirst-half profit, hurt by a fall in sales. (Reporting by Kit Rees; Editing by Toby Chopra)

More News
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.